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ABSTRACT
Oral lichen planus (OLP) is a common chronic disease of uncertain origin. Many patients with OLP are refractory to 
all available therapies. The photodynamic therapy (PDT) was used as a possible alternative method in the treatment of 
lichen planus. Two patients with five oral lichen planus lesions were treated using topical PDT mediated by methylene blue 
(MB-PDT). The patients were followed up on sessions 3, 7, 15 days and 1 to 9 months after PDT. Clinical improvement 
was achieved in four lesions. Two lesions showed complete remission, and another two lesions had about 50% clinically 
improvement 3-9 months after a single session of PDT. No response detected in one lesion. MB-PDT blue seems to be 
an effective alternative treatment for control of OLP. In our opinion, this preliminary result warrant further studies in 
order to show the efficacy of MB-PDT in control of OLP for a longer period of time.
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INTRODUCTION
Lichen planus (LP) is a relatively common, chronic derma-
tologic disease that often affects the oral mucosa (1). OLP is 
reported to occur in 0.5 2.2% of the population, with a peak 
incidence in the 30-60 years age range and with a female 
predominance of 2:1. Unlike oral lesion, skin lesions are 
usually self  limited, lasting only one year or less. 
The etiology of LP involves a cell-mediated immunologically 
induced degeneration of the basal cell layer of epithelium 
(1). Two basic types of lesion occur: totally white (keratotic) 
and white (keratotic) with red (atrophic, erosive, bullous) (2). 
The occurrence of squamous cell carcinoma in most series 
ranges from 0.4 to 2% per a 5-year observation period (3). 
Treatment options of OLP are numerous, including topical 
and systemic agents (4). Because LP is an immunologically 
mediated condition, corticosteroids are recommended. 
Topical corticosteroids remain the mainstay of  therapy. 
However, therapeutic results are often disappointing.
Photodynamic therapy (PDT) is an effective therapy for 
premalignant and malignant cutaneous lesions (5). It has 
also been reported as effective in treating psoriasis. We are 
reporting the results of oral lichen planus with Methylene 
blue mediated PDT in two cases.
CASE REPORTS
The Patients were referred to the clinic of Iranian center for 
medical laser (ICML), ACECR, to undergo PDT. Methylene 
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blue (MB) was used as photosensitizer. It was prepared 0.05 
gr per 100 cc. Ten minutes prior to laser irradiation, patients 
gargled MB for 5 minutes. A diode laser (Lumina®,Russia; 
632 nm, CW) was used as light source. The lesions and 1 cm 
of their surrounding marginal zone were illuminated with 
a spot size of 2.5-3 cm2. Large lesions were illuminated 
with multiple spots. A fluence of 100 J/cm2 was used. The 
patients were followed up on sessions 3,7,15 days and 1 to 
9 months after PDT. At the follow up sessions; lesions were 
examined to detect any residual lesion. Lesions were exactly 
measured and digital photographs were taken before PDT 
and at follow up session. Response rates were assessed clini-
cally by amount of reduction in surface area of lesions.
Patient 1
A 52-year-old woman was referred to Oral Medicine De-
partment of Tehran University by a specialist. Her medical 
history was positive for hypertension and taking propranolol 
and fluxitin.
Her complaint was burning sense. Clinical examination 
revealed an atrophic area with white steria in her right man-
dibular and left maxillary gingiva vestibule (Figure 1). 
Before treatment we use vital staining with toluidine blue 
for rule out of malignancy, then patient signed a written 
consent statement after receiving a full verbal explanation 
of treatment, including the potential benefits and risks of 
treatment. One week after a single session of PDT the lesions 
completely disappeared .and results of treatment were stable 
for 9 consecutively months of following.
Patient 2
A 60-year-old man with a 12-year history of  OLP had 
previously been treated with topical steroids. He had three 
keratotic lesions in left and right buccal mucosa and tongue.
patient signed a written informed consent statement after 
receiving a full verbal explanation of treatment, including 
the potential benefits and risks of treatment (Figure 2). 
Fig. 1.  Atrophic and keratotic lichen planus lesion on the left upper gingival before photodynamic therapy (PDT) (A). Complete response after 
9 months follow-up (B).
Fig. 2. Keratotic lichen planus lesion on the left buccal mucosa before photodynamic therapy (PDT) (A). Partial response after 2 months 
follow-up (B).
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He was treated as the same method as mentioned above. A 
week after treatment reduction size in right buccal lesion 
was about 40% and in left lesion 20%. Tongue lesion shows 
no sign of response, results of treatment were stable for 2 
months of following.
DISCUSSION
Oral lichen planus (OLP) is a chronic inflammatory disease 
characterized by relapses and remissions. It is a cell-me-
diated immune condition of unknown etiology, in which 
T lymphocytes accumulate beneath the epithelium of the 
oral mucosa and increase the rate of differentiation of the 
stratified squamous epithelium, resulting in hyperkeratosis 
and erythema with or without ulceration (1).
There is currently no cure for OLP. Treatment is aimed 
primarily at reducing the length and severity of sympto-
matic outbreaks. Topical steroids are the first choice agent 
for the treatment of symptomatic, active OLP (4). Other 
topical agents that have been used in cases resistant to to-
pical steroids include retinoids, azathioprine, cyclosporine, 
tacrolimus, and mycophenolate mofetil. Oral and topical 
PUVA therapy with low-dose UVA is effective in treating 
OLP of the various forms, but it seems to have too many 
side-effects, mainly nausea and the potential for carcinoge-
nicity (6). Topical application of psoralen is promising, but 
still experimental.
The treatment of  dysplastic LP may require additional 
approaches directed at dysplastic/genetic changes that make 
use of current management for oral dysplasia, in addition 
to the anti-inflammatory management reviewed earlier (7). 
Current approaches to the management of oral dysplastic 
lesions include excision (laser or surgical), topical thera-
pies including vitamin A and vitamin A analogues, topical 
chemotherapy (such as bleomycin), and systemic treatment 
with vitamin A analogues and other miscellaneous agents 
(7). The treatment of  symptomatic OLP, especially the 
erosive variant, represents a perplexing therapeutic cha-
llenge. Despite numerous existing remedies, there are many 
treatment failures. 
One such promising modality is photodynamic therapy 
(PDT). PDT is a technique that uses a photosensitizing 
compound, activated at a specific wavelength of laser light, 
to destroy the targeted cell via strong oxidizers, which cause 
cellular damage, membrane lysis, and protein inactivation 
(8). PDT has been used with relative success in the field of 
oncology, notably in head and neck tumors (9). 
The exact mechanism of action of PDT is unclear. It would 
appear to act on hyperproliferating cells, such as are pre-
sent in malignancies and psoriasis, with selective uptake of 
photosensitizers into these cells (10). It has been suggested 
that PDT may have immunomodulatory effects and may 
induce apoptosis in the hyperproliferating inflammatory 
cells which are present in psoriasis and lichen planus. This 
may reverse the hyperproliferation and inflammation of 
lichen planus. 
Nearly a century ago the antibacterial characteristics of the 
phenothiazine dye Methylene blue (MB) were described and 
attributed to its photodynamic 6 properties. MB itself  has 
been used in medical practice for more than 100 years and 
is recognized as having very low tissue toxicity. Clinical uses 
of MB include the treatment of ifosfamide encephalopathy, 
methemoglobinemia, urolithiasis, and cyanide poisoning 
(11). In addition, 0.5% MB is commonly used to stain the 
esophagus of patients with a history of Barrett’s esophagus 
and the bronchial lesions/pulmonary nodules of potential 
lung cancer patients (12). MB can be administered to human 
beings orally or intravenously in high doses without any 
toxic effects (13). Unlike other photosensitizers; MB can be 
administered topically and orally and it may be a preferred 
choice for superficial lesions in skin and oral cavity. The fact 
that MB has a strong absorption at wavelengths longer than 
620 nm, where light penetration into tissue is optimal, has 
led to the using of MB as a promising candidate for PDT. 
Pervious studies showed ALA-mediated PDT that in addi-
tion to being a somewhat painful therapy, the drug when 
topically applied does not penetrate deeply (14).
In this study, five lesions had been treated with MB-mediated 
PDT. Two lesions completely resolved (Complete respon-
se). A partial response (more than 50% improvement) was 
observed in two other lesions. There was no recurrence in 
improved lesions after 9 months follow-up. No improvement 
was observed in lesion on the tongue. 
We could find one report of the use of PDT for hypertro-
phic lichen planus of the penis (15). Kirby and et al. used 
ALA-mediated PDT twice for treating of the lesion. The 
lesion had completely resolved after 4 weeks. At 6-month 
follow-up there was no recurrence. 
We believe this therapy may be effective in the treatment of 
oral lichen planus as well as neoplastic conditions. Further 
studies are needed to confirm the efficacy of PDT in the 
treatment of oral lichen planus. 
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